Cosette Pharmaceuticals

Executive Summary

Cosette Pharmaceuticals is a privately-held U.S. generic drug company founded in 2008 and headquartered in Cranford, New Jersey. The company currently markets four commercial products, though details on specific drugs and therapeutic areas remain limited due to its private status. Cosette operates in the competitive generic pharmaceuticals space, where margins are pressured but demand for affordable medications remains high. The company likely focuses on niche or hard-to-manufacture generics, as suggested by its modest product portfolio. With no disclosed funding rounds or valuation, Cosette appears to be a self-sustaining player, potentially generating steady cash flow from its existing products. However, growth will depend on its ability to expand its pipeline and secure FDA approvals for new abbreviated new drug applications (ANDAs). The company's private nature makes it challenging to assess financial health, but its longevity since 2008 suggests operational resilience.

Upcoming Catalysts (preview)

• Q3 2026FDA Approval of New ANDA60% success
• Q4 2026Strategic Partnership or Licensing Deal40% success
• Q1 2027Launch of Additional Generic Product50% success